Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Return on Equity [ROE] (2018 - 2021)

Updated

Sigyn Therapeutics (SIGY) recorded Return on Equity [ROE] of -6416.84% in Q4 2021, down 6082.92 percentage points from the prior quarter.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Return on Equity [ROE] (2018 - 2021) Analysis & Trends

For FY2020, Sigyn Therapeutics reported Return on Equity [ROE] of -2563.56%.

  • Quarterly Return on Equity [ROE] has ranged from -13340.37% in Q1 2020 to -333.91% in Q3 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -333.91% (Q3 2021), -382.24% (Q2 2021) and -12468.61% (Q1 2021).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -6,416.84%
Sep 30, 2021 -333.91%
Jun 30, 2021 -382.24%
Mar 31, 2021 -12,468.61%
Mar 31, 2020 -13,340.37%
Jun 30, 2018 -10,515.48%
API Access

Sigyn Therapeutics, Inc. Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SIGY&period=max&api_key=YOUR_API_KEY